Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 5, 2003Blood

Continuous absence of metaphase-defined cytogenetic abnormalities, especially of chromosome 13 and hypodiploidy, ensures long-term survival in multiple myeloma treated with Total Therapy I: interpretation in the context of global gene expression

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJohn D. ShaughnessyWinthrop Rockefeller FoundationJJJoth JacobsonW. L. Gore & Associates (United States)JSJeff SawyerUniversity of Maryland, Baltimore

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shaughnessy et al. (2003) studied this question.

synapsesocial.com/papers/6a10ee4e497e609eda647842https://doi.org/10.1182/blood-2002-09-2873
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy2001 · 315 citations
  2. 2A growing set of platelet-activating bacterial proteins2002 · 4 citations
  3. 3Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia2001 · 198 citations
  4. 4Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase1997 · 223 citations
  5. 5Nonparametric Estimation from Incomplete Observations1958 · 39,539 citations